136 related articles for article (PubMed ID: 29982754)
1. Neurocognitive Sequelae in Adult Childhood Leukemia Survivors Related to Levels of Phosphorylated Tau.
Elens I; Deprez S; Danckaerts M; Bijttebier P; Labarque V; Uyttebroeck A; Van Gool S; D'Hooge R; Lemiere J
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 29982754
[TBL] [Abstract][Full Text] [Related]
2. Intellectual functioning of childhood leukemia survivors--relation to Tau protein--a marker of white matter injury.
Krawczuk-Rybak M; Grabowska A; Protas PT; Muszynska-Roslan K; Holownia A; Braszko J
Adv Med Sci; 2012; 57(2):266-72. PubMed ID: 23154429
[TBL] [Abstract][Full Text] [Related]
3. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
[TBL] [Abstract][Full Text] [Related]
4. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD
Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
[TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate Affects Cerebrospinal Fluid Folate and Tau Levels and Induces Late Cognitive Deficits in Mice.
Elens I; Dekeyster E; Moons L; D'Hooge R
Neuroscience; 2019 Apr; 404():62-70. PubMed ID: 30703509
[TBL] [Abstract][Full Text] [Related]
10. Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia.
Cheung YT; Khan RB; Liu W; Brinkman TM; Edelmann MN; Reddick WE; Pei D; Panoskaltsis-Mortari A; Srivastava D; Cheng C; Robison LL; Hudson MM; Pui CH; Krull KR
JAMA Oncol; 2018 Jul; 4(7):e180089. PubMed ID: 29596541
[TBL] [Abstract][Full Text] [Related]
11. Negative correlation between cerebrospinal fluid tau protein and cognitive functioning in children with acute lymphoblastic leukemia.
Protas PT; Muszynska-Roslan K; Holownia A; Grabowska A; Wielgat P; Krawczuk-Rybak M; Braszko JJ
Pediatr Blood Cancer; 2009 Jul; 53(1):105-8. PubMed ID: 19309718
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma.
Edelmann MN; Daryani VM; Bishop MW; Liu W; Brinkman TM; Stewart CF; Mulrooney DA; Kimberg C; Ness KK; Cheung YT; Srivastava DK; Robison LL; Hudson MM; Krull KR
JAMA Oncol; 2016 Feb; 2(2):201-8. PubMed ID: 26583357
[TBL] [Abstract][Full Text] [Related]
13. Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.
Cheung YT; Edelmann MN; Mulrooney DA; Green DM; Chemaitilly W; John N; Robison LL; Hudson MM; Krull KR
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1259-67. PubMed ID: 27345588
[TBL] [Abstract][Full Text] [Related]
14. Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study.
Petrykey K; Lippé S; Robaey P; Sultan S; Laniel J; Drouin S; Bertout L; Beaulieu P; St-Onge P; Boulet-Craig A; Rezgui A; Yasui Y; Sapkota Y; Krull KR; Hudson MM; Laverdière C; Sinnett D; Krajinovic M
PLoS One; 2019; 14(6):e0217314. PubMed ID: 31181069
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate-induced alterations in beta-oxidation correlate with cognitive abilities in children with acute lymphoblastic leukemia.
Moore IM; Miketova P; Hockenberry M; Krull K; Pasvogel A; Carey M; Kaemingk K
Biol Res Nurs; 2008 Apr; 9(4):311-9. PubMed ID: 18398226
[TBL] [Abstract][Full Text] [Related]
16. Methylene tetrahydrofolate reductase A1298C polymorphisms influence the adult sequelae of chemotherapy in childhood-leukemia survivors.
Elens I; Deprez S; Billiet T; Sleurs C; Labarque V; Uyttebroeck A; Van Gool S; Lemiere J; D'Hooge R
PLoS One; 2021; 16(4):e0250228. PubMed ID: 33930029
[TBL] [Abstract][Full Text] [Related]
17. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
Zając-Spychała O; Wachowiak J
Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657
[TBL] [Abstract][Full Text] [Related]
18. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR
J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review.
Cheung YT; Krull KR
Neurosci Biobehav Rev; 2015 Jun; 53():108-20. PubMed ID: 25857254
[TBL] [Abstract][Full Text] [Related]
20. DIVERGT screening procedure predicts general cognitive functioning in adult long-term survivors of pediatric acute lymphoblastic leukemia: A PETALE study.
Boulet-Craig A; Robaey P; Laniel J; Bertout L; Drouin S; Krajinovic M; Laverdière C; Sinnett D; Sultan S; Lippé S
Pediatr Blood Cancer; 2018 Sep; 65(9):e27259. PubMed ID: 29797640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
